GCI Virtual Summit Thought Leader – Shane Duncan, Cann Group

GCI Summit - Shane Duncan - Cann Group - Global Cannabis Intelligence - GCI Virtual Summit

GCI Virtual Summit Thought Leader – Shane Duncan, Cann Group

Shane participated as a thought leader at the GCI Virtual Summit 2020, joining 1000+ registered global leaders in both cannabis and psychedelics.

Check out his bio below:

Shane Duncan joined Cann Group in December 2018 and is a broadly skilled consumer healthcare, medical device and pharmaceutical sales and marketing executive with a proven record of launching, establishing, and growing businesses/brands/commercial opportunities. Shane currently oversees the Commercial, Cultivation, Manufacturing and R&D programs for Cann Group. He has extensive global experience in strategy development, pre-commercialisation planning, medical education and product launch execution for several high value products.

Shane Duncan established and lead the Nth American Commercial Operations for Australian start-up company Rhinomed (ASX:RNO) for 3 years and has broad operational experience in a number of therapeutic areas including Respiratory, Sleep, Pain Management, Exercise Science and Fitness, Neuroscience, Cardiology, Endocrinology, and Vaccines.

If you are a leader operating in either the cannabis or psychedelics industries, check out the GCI Virtual Summit today! You can submit an application for a complimentary ticket for our 2021 Summit here.

You can also check out exclusive interviews with some of our GCI Virtual Summit thought leaders on the Content Hub.

Previous articleGCI Virtual Summit Thought Leader – Owen Bennett, Jefferies
Next articleGCI Virtual Summit Thought Leader – Peter Crock, Cann Group